Human cytochrome P450 2A13 efficiently metabolizes chemicals in air pollutants: naphthalene, styrene, and toluene.

Human P450 2A13 is the most efficient enzyme for catalyzing the metabolism of nicotine and metabolic activation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK). It is conceivable that P450 2A13 also metabolizes chemicals in air pollutants because this enzyme is highly expressed in the respiratory tract. In this study, we investigated the possibility that P450 2A13 can metabolize naphthalene, styrene, and toluene, which are included in air pollutants as well as tobacco smoke, although they were known to be metabolized by P450 1A2 or 2E1. We found that P450 2A13 catalyzed 1- and 2-naphthol formations from naphthalene with higher intrinsic clearances ( kcat/ Km) (3.1- and 2.2-fold, respectively) than P450 1A2 and also more efficiently catalyzed the styrene 7,8-oxide formation from styrene and the benzylalcohol formation from toluene than P450 2E1. The overlapping substrate specificity of P450 2A13 with P450 2E1 was supported by the finding that P450 2A13 catalyzed chlorzoxazone 6-hydroxylation (8-fold higher value of kcat/ Km) and p-nitrophenol 2-hydroxylation (19-fold higher value of kcat/ Km), which are marker activities of P450 2E1. Thus, we found that P450 2A13 metabolizes diverse environmental chemicals and has overlapping substrate specificities of P450 1A2 and 2E1, suggesting that P450 2A13 plays important roles in the local metabolism of environmental chemicals in the respiratory tract related to toxicity or carcinogenicity.

[1]  H. Kamin,et al.  Microsomal triphosphopyridine nucleotide-cytochrome c reductase of liver. , 1962, The Journal of biological chemistry.

[2]  CYP 2 A 13 Metabolizes the Substrates of Human CYP 1 A 2 , Phenacetin , and Theophylline , 2007 .

[3]  J. Lafitte,et al.  Genetic polymorphism of the human cytochrome CYP2A13 in a French population: implication in lung cancer susceptibility. , 2004, Biochemical and biophysical research communications.

[4]  M Pirmohamed,et al.  Characterisation of the toxic metabolite(s) of naphthalene. , 1996, Toxicology.

[5]  Y. Yasukochi,et al.  Some properties of a detergent-solubilized NADPH-cytochrome c(cytochrome P-450) reductase purified by biospecific affinity chromatography. , 1976, The Journal of biological chemistry.

[6]  M. Caggana,et al.  Genetic polymorphisms of the human CYP2A13 gene: identification of single-nucleotide polymorphisms and functional characterization of an Arg257Cys variant. , 2002, The Journal of pharmacology and experimental therapeutics.

[7]  T. Omura,et al.  THE CARBON MONOXIDE-BINDING PIGMENT OF LIVER MICROSOMES. I. EVIDENCE FOR ITS HEMOPROTEIN NATURE. , 1964, The Journal of biological chemistry.

[8]  C. Plopper,et al.  Relationship of cytochrome P450 activity to Clara cell cytotoxicity. IV. Metabolism of naphthalene and naphthalene oxide in microdissected airways from mice, rats, and hamsters. , 1995, Molecular pharmacology.

[9]  H. Yamazaki,et al.  Eighteen novel polymorphisms of the CYP2A13 gene in Japanese. , 2003, Drug metabolism and pharmacokinetics.

[10]  H. Yamazaki,et al.  Roles of NADPH-P450 reductase and apo- and holo-cytochrome b5 on xenobiotic oxidations catalyzed by 12 recombinant human cytochrome P450s expressed in membranes of Escherichia coli. , 2002, Protein expression and purification.

[11]  O Pelkonen,et al.  A genetic polymorphism in coumarin 7-hydroxylation: sequence of the human CYP2A genes and identification of variant CYP2A6 alleles. , 1995, American journal of human genetics.

[12]  S. Anttila,et al.  Expression of CYP2A genes in human liver and extrahepatic tissues. , 1999, Biochemical pharmacology.

[13]  Jia-Sheng Wang,et al.  Efficient activation of aflatoxin B1 by cytochrome P450 2A13, an enzyme predominantly expressed in human respiratory tract , 2006, International journal of cancer.

[14]  R. Tukey,et al.  Human cytochrome P450 isoform specificity in the regioselective metabolism of toluene and o-, m- and p-xylene. , 1996, The Journal of pharmacology and experimental therapeutics.

[15]  C. Kuo,et al.  The detection of cytochrome P450 2E1 and its catalytic activity in rat testis. , 1998, Biochemical and biophysical research communications.

[16]  W. Tan,et al.  Substantial reduction in risk of lung adenocarcinoma associated with genetic polymorphism in CYP2A13, the most active cytochrome P450 for the metabolic activation of tobacco-specific carcinogen NNK. , 2003, Cancer research.

[17]  Ernest Hodgson,et al.  IN VITRO METABOLISM OF NAPHTHALENE BY HUMAN LIVER MICROSOMAL CYTOCHROME P450 ENZYMES , 2006, Drug Metabolism and Disposition.

[18]  T. Fukami,et al.  CYP2A13 Metabolizes the Substrates of Human CYP1A2, Phenacetin, and Theophylline , 2007, Drug Metabolism and Disposition.

[19]  F. Gonzalez,et al.  The CYP2A3 gene product catalyzes coumarin 7-hydroxylation in human liver microsomes. , 1990, Biochemistry.

[20]  Jun-yan Hong,et al.  The missense genetic polymorphisms of human CYP2A13: functional significance in carcinogen activation and identification of a null allelic variant. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.

[21]  Jun-yan Hong,et al.  METABOLISM OF NICOTINE AND COTININE BY HUMAN CYTOCHROME P450 2A13 , 2005, Drug Metabolism and Disposition.

[22]  J Jeyaratnam,et al.  Chronic neurobehavioural effects of toluene. , 1990, British journal of industrial medicine.

[23]  Bond Ja.  Review of the toxicology of styrene. , 1989 .

[24]  D. Greenblatt,et al.  Biotransformation of Chlorzoxazone by Heptatic Microsomes from Humans and Ten Other Mammalian Species , 1997, Biopharmaceutics & drug disposition.

[25]  E. Ford,et al.  Genetic polymorphism , 2020, Proceedings of the Royal Society of London. Series B. Biological Sciences.

[26]  Beatriz Pérez-Cadahía,et al.  Individual sensitivity to DNA damage induced by styrene in vitro: influence of cytochrome p450, epoxide hydrolase and glutathione S-transferase genotypes. , 2003, Toxicology.

[27]  D. Bagchi,et al.  Naphthalene-induced oxidative stress in rats and the protective effects of vitamin E succinate. , 1996, Free radical biology & medicine.

[28]  H. Yamazaki,et al.  Characterization of microsomal cytochrome P450 enzymes involved in the oxidation of xenobiotic chemicals in human fetal liver and adult lungs. , 1996, Drug metabolism and disposition: the biological fate of chemicals.

[29]  D. Morin,et al.  Metabolism and cytotoxicity of naphthalene oxide in the isolated perfused mouse lung. , 1991, The Journal of pharmacology and experimental therapeutics.

[30]  V. Vilker,et al.  Application of Pseudomonas putida PpG 786 Containing P‐450 Cytochrome Monooxygenase for Removal of Trace Naphthalene Concentrations , 1991 .

[31]  Jun-yan Hong,et al.  Human cytochrome P450 CYP2A13: predominant expression in the respiratory tract and its high efficiency metabolic activation of a tobacco-specific carcinogen, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. , 2000, Cancer research.

[32]  F. Guengerich,et al.  Role of human cytochrome P-450 IIE1 in the oxidation of many low molecular weight cancer suspects. , 1991, Chemical research in toxicology.

[33]  A. Poso,et al.  Predictive value of comparative molecular field analysis modelling of naphthalene inhibition of human CYP2A6 and mouse CYP2A5 enzymes. , 2003, Toxicology in vitro : an international journal published in association with BIBRA.

[34]  Hiroshi Yamazaki,et al.  CYP2A13 expressed in human bladder metabolically activates 4‐aminobiphenyl , 2006, International journal of cancer.

[35]  H. McLeod,et al.  A novel polymorphism of human CYP2A6 gene CYP2A6*17 has an amino acid substitution (V365M) that decreases enzymatic activity in vitro and in vivo , 2004, Clinical pharmacology and therapeutics.

[36]  B. Sanderson,et al.  A recombinant model for assessing the role of GSTM1 in styrene-7,8-oxide toxicity and mutagenicity. , 2004, Toxicology.

[37]  Lesley-Anne Sayers.  SERGEI DIAGHILEV'S "SOVIET" BALLET: LE PAS D'ACIER AND ITS RELATIONSHIP TO RUSSIAN CONSTRUCTIVISM* , 1996 .

[38]  M. Caggana,et al.  Development of a Real-Time Polymerase Chain Reaction-Based Method for the Measurement of Relative Allelic Expression and Identification of CYP2A13 Alleles with Decreased Expression in Human Lung , 2004, Journal of Pharmacology and Experimental Therapeutics.

[39]  Jun-yan Hong,et al.  CYP2A13 in Human Respiratory Tissues and Lung Cancers: An Immunohistochemical Study with A New Peptide-Specific Antibody , 2006, Drug Metabolism and Disposition.

[40]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[41]  J. A. Bond.  Review of the toxicology of styrene. , 1989, Critical reviews in toxicology.

[42]  C David Stout,et al.  Adaptations for the Oxidation of Polycyclic Aromatic Hydrocarbons Exhibited by the Structure of Human P450 1A2*♦ , 2007, Journal of Biological Chemistry.

[43]  D. Hémon,et al.  Retrospective evaluation of the exposure to polycyclic aromatic hydrocarbons: comparative assessments with a job exposure matrix and by experts in industrial hygiene. , 1993, International journal of epidemiology.

[44]  Y. Chen,et al.  Expression of biotransformation enzymes in human fetal olfactory mucosa: potential roles in developmental toxicity. , 2000, Toxicology and applied pharmacology.

[45]  T. Aoyama,et al.  Styrene metabolism by cDNA-expressed human hepatic and pulmonary cytochromes P450. , 1994, Chemical research in toxicology.

[46]  F. Guengerich,et al.  Drug metabolism by Escherichia coli expressing human cytochromes P450 , 1997, Nature Biotechnology.

[47]  T. Aoyama,et al.  Toluene metabolism by cDNA-expressed human hepatic cytochrome P450. , 1997, Biochemical pharmacology.

[48]  C. Stout,et al.  Structure of the Human Lung Cytochrome P450 2A13* , 2007, Journal of Biological Chemistry.

[49]  T. Fukami,et al.  CYP2A6 AND CYP2B6 ARE INVOLVED IN NORNICOTINE FORMATION FROM NICOTINE IN HUMANS: INTERINDIVIDUAL DIFFERENCES IN THESE CONTRIBUTIONS , 2005, Drug Metabolism and Disposition.